Vulvar Diseases

12 registered clinical trials studyying Vulvar Diseases — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Danish Vulva Cancer Recurrence Study NCT06495554	University of Aarhus	N/A
Recruiting	Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Prem NCT06070454	University of Virginia	N/A
Recruiting	Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions NCT06075264	Frantz Viral Therapeutics, LLC	Phase 2
Recruiting	Vulvar Disease in Nigeria Observational Study NCT05890092	KDRS ltd	—
Recruiting	A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Part NCT05592626	Marengo Therapeutics, Inc.	Phase 1 / Phase 2
Completed	Effects of Flourish HEC on Localized Provoked Vulvodynia NCT05478746	Vaginal Biome Science	N/A
Completed	Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) NCT03792516	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1
Terminated	Treatment Prior to Injection and Biopsy of the Vulva NCT03444727	University of Missouri-Columbia	N/A
Completed	E7 TCR T Cells for Human Papillomavirus-Associated Cancers NCT02858310	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis NCT00496184	Western Galilee Hospital-Nahariya	Phase 3
Unknown	Botox on Vulvar Vestibulitis NCT00119886	Rigshospitalet, Denmark	Phase 4
Completed	Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis NCT00004316	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 1 / Phase 2